🔎 Trials Near Me

Utama › Hipertiroidisme › California

Kajian klinikal Hipertiroidisme di California

7 kajian untuk Hipertiroidisme sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

  • AME Clinical Research, Los Angeles
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07722546

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

  • Site-032, Burbank
  • Site-062, Huntington Beach
  • Site-048, Oakland
  • dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07661056

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

  • Site # 1111, Torrance
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07305818

Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

  • Site 121, La Mesa
  • Site 103, Sacramento
  • Site 111, San Francisco
  • dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07682896

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

  • Site Number - 1061, Huntington Beach
  • Site Number - 1001, Los Angeles
  • Site Number - 1047, Los Angeles
  • dan 4 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT06727604

Study of BHV-1300 in Graves' Disease

  • Site-103, South Gate
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06980649

Evaluating an AI Tool for Detecting Thyrotoxic States

  • Umesh Masharani, San Francisco
Mengambil pesertaKajian pemerhatian
Umur 22 ke atas · Semua jantina · Dikemas kini 1 Jun 2026 · NCT07017907

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.